瑞典全国队列:透析与肾移植患者COVID-19疫苗接种前后结局
疫苗接种开始后,透析患者第三波(2021年4月)全因死亡率回落至COVID-19前水平,而移植受者死亡率仍升高;透析患者疫情早期住院和死亡风险高于移植受者,接种后风险低于移植受者。
要点
- 疫苗接种前透析患者COVID-19住院和死亡风险高于肾移植受者(aOR 2.1),接种后风险低于移植受者(aOR 0.5)。
- 疫苗接种开始后透析患者第三波全因死亡率回落至COVID-19前水平,移植受者仍升高。
- 瑞典对肾脏替代治疗患者早期优先接种疫苗可能挽救了许多生命。
核心结论
- 瑞典COVID-19大流行导致肾脏替代治疗患者死亡和住院率增加;疫苗接种开始后透析患者住院和死亡率明显下降,但移植受者未见下降。
主要发现
- 2020年1月1日透析患者4097例(中位年龄70岁),肾移植受者5905例(中位年龄58岁)。
- 2020年3月至2021年2月,透析患者平均全因死亡率较2019年同期升高10%(从720例增至804例死亡),移植受者升高22%(从158例增至206例死亡)。
- 疫苗接种开始后,透析患者第三波(2021年4月)全因死亡率回落至COVID-19前水平,移植受者死亡率仍升高。
- 疫苗接种前透析患者COVID-19住院和死亡风险高于移植受者(aOR 2.1,95%CI 1.7-2.5),接种后风险低于移植受者(aOR 0.5,95%CI 0.4-0.7)。
临床怎么用
- 瑞典对肾脏替代治疗患者早期优先接种COVID-19疫苗,可能挽救了许多生命。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients on kidney replacement therapy (KRT) have been identified as a vulnerable group during the coronavirus disease 2019 (COVID-19) pandemic. This study reports the outcomes of COVID-19 in KRT patients in Sweden, a country where patients on KRT were prioritized early in the vaccination campaign. METHODS: Patients on KRT between January 2019 and December 2021 in the Swedish Renal Registry were included. Data were linked to national healthcare registries. The primary outcome was monthly all-cause mortality over 3 years of follow-up. The secondary outcomes were monthly COVID-19-related deaths and hospitalizations. The results were compared with the general population using standardized mortality ratios. The difference in risk for COVID-19-related outcomes between dialysis and kidney transplant recipients (KTRs) was assessed in multivariable logistic regression models before and after vaccinations started. RESULTS: On 1 January 2020, there were 4097 patients on dialysis (median age 70 years) and 5905 KTRs (median age 58 years). Between March 2020 and February 2021, mean all-cause mortality rates increased by 10% (from 720 to 804 deaths) and 22% (from 158 to 206 deaths) in dialysis and KTRs, respectively, compared with the same period in 2019. After vaccinations started, all-cause mortality rates during the third wave (April 2021) returned to pre-COVID-19 mortality rates among dialysis patients, while mortality rates remained increased among transplant recipients. Dialysis patients had a higher risk for COVID-19 hospitalizations and death before vaccinations started {adjusted odds ratio [aOR] 2.1 [95% confidence interval (CI) 1.7-2.5]} but a lower risk after vaccination [aOR 0.5 (95% CI 0.4-0.7)] compared with KTRs. CONCLUSIONS: The COVID-19 pandemic in Sweden resulted in increased mortality and hospitalization rates among KRT patients. After vaccinations started, a distinct reduction in hospitalization and mortality rates was observed among dialysis patients, but not in KTRs. Early and prioritized vaccinations of KRT patients in Sweden probably saved many lives.
引用
- Wijkström J, Caldinelli A, Bruchfeld A, et al. Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19. Nephrol Dial Transplant. 2023. PMID: 37433606. doi:10.1093/ndt/gfad151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。